Huron consulting director McCartney sells $63,840 in stock

Director John McCartney sold 500 HURN shares on Apr 1, 2026 at $127.68 for $63,840 under a pre-arranged 10b5-1 plan and now owns 40,817 shares. Huron reported Q4 adjusted EPS $2.17 vs $1.95 consensus and revenue before reimbursables $432.3M (+11.3%) vs $433.57M consensus (slight miss); shares dropped after management issued a wide 2026 guidance range amid concerns over AI impact. Benchmark reiterated a Buy and $215 price target after modest model tweaks and initiating a 2027 outlook. Shares trade near $130.35, down ~25% YTD, reflecting mixed fundamentals and guidance-driven uncertainty.

Analysis

Mid-cap management consultancies are at an inflection where AI acts as both demand accelerator and a margin compressor: firms that can productize repeatable transformation work will capture outsized EBITDA expansion, while those reliant on time-and-materials advisory risk rate pressure as clients demand outcome-based contracts and embedded tooling. Huron sits in an advantageous niche—industry-specialized transformation in healthcare and commercial verticals—so the second-order winners are boutique platform builders (specialist implementation firms that turn IP into recurring revenue) and SaaS vendors who can embed consulting services into subscription bundles.

Key risks crystallize across three horizons. In the near term (days–weeks) sentiment and guidance noise can drive outsized volatility; in the medium term (3–12 months) the trajectory depends on the share of fixed-fee, productized engagements versus one-off professional services; in the long term (1–3 years) macro capex cycles and regulatory headwinds in healthcare could delay AI implementations and compress utilization. Reversals will come from either proof points of scalable, repeatable project wins (positive) or rapid commoditization of implementation work by large systems integrators (negative).

Consensus frames the wide planning range as pure downside; the contrarian angle is that a wider range is consistent with active portfolio reallocation toward productized offerings—a transient re-rating opportunity. A paired approach (capture re-rating while hedging structural AI risk) and option structures that limit downside while preserving upside seem the most efficient ways to play asymmetry over the next 6–18 months.

Key Decisions for Investors

• Pair trade (6–12 months): Long HURN equity (size 1.5–2% NAV) paired with a smaller short position in ACN (size 0.8–1% NAV) to express mid-cap re-rating vs scale integrator outperformance; target asymmetric payoff ~2:1, stop-loss 8% on the pair relative move.
• Options trade (6–18 months): Buy a 12–18 month call spread on HURN: long 30% OTM calls / sell 60% OTM calls to cap cost while retaining 2–3x upside if guidance narrows positively; keep position size <1% NAV given gamma risk.
• Event-driven swing (0–3 months): Initiate a tactical long HURN into the next quarterly update on a pullback >10% from current levels, with a tight 12–15% stop and take-profit at 25–35% reflecting a likely sentiment-driven bounce if margin guide tightens.
• Hedge/insurance (12 months): Buy a small position in large systems integrators (e.g., ACN) or long-dated puts on HURN if conviction in AI commoditization rises; this reduces portfolio skew should implementation work be captured by scale players.